Mackay Shields LLC’s Thermo Fisher Scientific TMO Stock Holding History

Mackay Shields LLC’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-56,647	Closed	-$33.5M	–	654
2022 Q1	$33.5M	Sell	56,647 -2,226	-4%	-$1.28M	0.29%	84
2021 Q4	$39.3M	Sell	58,873 -1,252	-2%	-$782K	0.33%	77
2021 Q3	$34.4M	Sell	60,125 -1,739	-3%	-$954K	0.32%	75
2021 Q2	$31.2M	Sell	61,864 -11,157	-15%	-$5.26M	0.29%	86
2021 Q1	$33.3M	Sell	73,021 -7,519	-9%	-$3.59M	0.24%	82
2020 Q4	$37.5M	Buy	80,540 +3,967	+5%	+$1.86M	0.26%	70
2020 Q3	$33.8M	Buy	76,573 +7,540	+11%	+$3.12M	0.23%	81
2020 Q2	$25M	Sell	69,033 -2,672	-4%	-$896K	0.2%	113
2020 Q1	$20.3M	Buy	71,705 +959	+1%	+$302K	0.19%	132
2019 Q4	$23M	Sell	70,746 -11,978	-14%	-$3.63M	0.16%	153
2019 Q3	$24.1M	Sell	82,724 -44,687	-35%	-$12.8M	0.15%	168
2019 Q2	$37.4M	Buy	127,411 +13,282	+12%	+$3.66M	0.26%	84
2019 Q1	$31.2M	Buy	114,129 +16,960	+17%	+$4.22M	0.23%	96
2018 Q4	$21.7M	Buy	97,169 +26,672	+38%	+$6.26M	0.18%	135
2018 Q3	$17.2M	Sell	70,497 -1,514	-2%	-$348K	0.13%	207
2018 Q2	$14.9M	Sell	72,011 -3,021	-4%	-$641K	0.1%	252
2018 Q1	$15.5M	Buy	+75,032	New	+$15.7M	0.1%	257

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's TMO Position: Q2 2022 in Review

Mackay Shields LLC sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 56,647 shares — an estimated $33.5M sold.

Mackay Shields LLC first reported a position in TMO in Q1 2018 and held it in 17 quarters. The position peaked at $39.3M in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Mackay Shields LLC reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
Mackay Shields LLC sold 56,647 Thermo Fisher Scientific shares in Q2 2022, an estimated $33.5M.
Mackay Shields LLC first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 17 quarters.
Mackay Shields LLC's Thermo Fisher Scientific position peaked at $39.3M in Q4 2021.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.